AGL Investor Alert: Securities Class Action Lawsuit Filed on Behalf of agilon health, inc. Investors

On February 4, 2026, the New York–based plaintiffs’ law firm Kirby McInerney LLP issued an important investor alert for individuals and institutions that purchased or acquired securities of agilon health, inc. (NYSE: AGL). The notice informs shareholders of a pending federal securities class action lawsuit and urges eligible investors to act before the upcoming lead plaintiff deadline of March 2, 2026.

About the Class Action Lawsuit

The class action lawsuit has been filed on behalf of investors who bought agilon health securities during the period from February 26, 2025 through August 4, 2025 (the “Class Period”). The complaint alleges that agilon health and certain of its senior officers made materially false and/or misleading statements regarding the Company’s business, financial performance, and prospects throughout the Class Period. These allegations are claimed to have artificially inflated the price of agilon’s stock, causing financial harm to investors when the truth emerged.

Allegations at the Center of the Lawsuit

According to the lawsuit referenced in the investor alert, the defendants are accused of:

• Recklessly issuing financial guidance for the fiscal year 2025 that they knew—or should have known—could not be achieved given material industry headwinds.
• Overstating the immediate positive financial impacts of so-called strategic actions taken by agilon health to reduce risk and improve performance.

The combined effect of these alleged misrepresentations is asserted to have misled investors about the Company’s true financial condition and prospects, contributing to stock price inflation during the Class Period.

Triggering Events and Stock Drop

On August 4, 2025, agilon health announced a leadership transition and disappointing second-quarter financial results. Specifically:

• The Company disclosed that Steven Sell, then President, CEO, and a member of the Board of Directors, stepped down from his positions.
• agilon health revealed it was suspending its previously issued full-year 2025 guidance due to stronger-than-expected industry headwinds.

In response to this news, agilon health’s share price plummeted sharply, dropping by over 50% in a single trading session—a significant loss that directly impacted shareholders who had purchased AGL stock during the alleged Class Period.

Deadline to Seek Lead Plaintiff Appointment

Investors who suffered losses and wish to participate more actively in the lawsuit are encouraged to file a motion with the court to be appointed as the lead plaintiff. The lead plaintiff plays a central role in representing the interests of the entire plaintiff class and can help direct key aspects of the litigation, such as strategy and settlement negotiations.

However, courts will not consider any applications submitted after the deadline of March 2, 2026. This timeline is critical for investors seeking to take on a leadership role in the litigation.

Who Is Eligible?

To qualify for lead plaintiff consideration, investors must have:

• Purchased or acquired agilon health securities between February 26, 2025 and August 4, 2025.
• Suffered a financial loss due to the alleged misrepresentations or omissions by the Company during the Class Period.

Eligible investors are encouraged to contact Kirby McInerney LLP promptly to discuss their legal options and to file the necessary documents with the court.

Contact Information and Legal Support

Kirby McInerney LLP has a long history of representing shareholders in complex securities litigation and has secured significant recoveries for investors in prior cases. The firm’s expertise spans securities, antitrust, whistleblower, and consumer litigation.

Investors with questions about the lawsuit, who believe they may be eligible to participate in the class action, or who wish to seek lead plaintiff appointment can reach out to Lauren Molinaro, Esq., of Kirby McInerney LLP. The firm has made contact information available, and discussions are offered at no cost to potential class members.

This alert serves as attorney advertising in some jurisdictions under applicable laws and ethical rules.

#AGL #agilonhealth #securitiesclassaction #investoralert #SlimScan #GrowthStocks #CANSLIM